Company filings profile · CIK 0001787740

Valion Bio, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Valion Bio, Inc. (VBIO): 26 filings in the last 90 days vs 21 in the prior 90 (filing-velocity rising ↑ · 1.24×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.

Material 8-K events — Valion Bio, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Jun 18, 2026Unregistered Sale of Securities; Other Events
Jun 3, 2026Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits
May 14, 2026Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits
May 4, 2026Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Apr 23, 2026Amendments to Bylaws/Charter; Financial Statements and Exhibits
Mar 25, 2026Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits
Mar 20, 2026Delisting / Listing-Rule Failure
Mar 13, 2026Entry into a Material Agreement; Financial Statements and Exhibits
Mar 11, 2026Item 5.07; Other Events
Mar 4, 2026Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Feb 9, 2026Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits
Jan 20, 2026Regulation FD Disclosure; Financial Statements and Exhibits

Watch Valion Bio, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Jun 18, 20264
May 20, 20264
May 4, 20264
May 4, 20263
Apr 20, 20264
Apr 2, 20264
Mar 19, 20264
Feb 20, 20264
Dec 22, 20254
Dec 22, 20254
Sep 24, 20254

Recent filings

FiledFormDetail
Jun 18, 20264
Jun 18, 20268-K Unregistered Sale of Securities; Other Events
Jun 5, 2026S-8 FORM S-8
Jun 5, 2026S-8 FORM S-8
Jun 3, 20268-K Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits
May 20, 20264
May 14, 202610-Q FORM 10-Q
May 14, 20268-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits
May 8, 2026SCHEDULE 13G/A
May 4, 20264
May 4, 20263
May 4, 20268-K Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Apr 30, 2026ARS ANNUAL REPORT
Apr 30, 2026DEF 14A DEFINITIVE PROXY STATEMENT
Apr 23, 20268-K Amendments to Bylaws/Charter; Financial Statements and Exhibits
Apr 20, 2026PRE 14A PRELIMINARY PROXY STATEMENT
Apr 20, 20264
Apr 15, 2026EFFECT Item ; Item ; Item
Apr 15, 2026424B3 PROSPECTUS
Apr 13, 2026CORRESP
Apr 13, 2026S-1 FORM S-1
Apr 9, 2026UPLOAD
Apr 6, 2026DRS
Apr 2, 20264
Mar 30, 202610-K FORM 10-K
Mar 25, 20268-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits
Mar 20, 20268-K Delisting / Listing-Rule Failure
Mar 19, 20264
Mar 13, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits
Mar 11, 20268-K Item 5.07; Other Events
Mar 4, 20268-K Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Feb 27, 2026SCHEDULE 13G
Feb 23, 20268-K/A Financial Statements and Exhibits
Feb 20, 20264
Feb 9, 2026DEFA14A FORM DEFA 14A
Feb 9, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits
Jan 20, 2026424B3 PROSPECTUS
Jan 20, 2026424B3 PROSPECTUS
Jan 20, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jan 16, 2026EFFECT Item ; Item ; Item